Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting

Pathology. 2022 Feb;54(1):116-120. doi: 10.1016/j.pathol.2021.10.001. Epub 2021 Nov 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Molecular Diagnostic Techniques
  • Nasopharynx
  • Prevalence
  • SARS-CoV-2*